Overview
EN ISO 13485:2016/A11:2021 is the European amendment (A11) to the international standard ISO 13485:2016 specifying quality management system (QMS) requirements for medical devices. Prepared by CEN/CLC/TC 3 and approved by CEN (12 April 2021, published September 2021), this amendment revises the European foreword and adds informative Annexes ZA and ZB to clarify the relationship between EN ISO 13485 and the EU medical device regulations (MDR 2017/745 and IVDR 2017/746). When cited in the Official Journal, compliance with relevant normative clauses provides a presumption of conformity for regulatory purposes within the limits of the standard’s scope.
Key topics and requirements
- Quality management for medical devices: Core QMS requirements from ISO 13485:2016 adopted for regulatory use in Europe.
- Relationship to EU Regulations: Annex ZA maps clauses to Regulation (EU) 2017/745 (MDR) and Annex ZB to Regulation (EU) 2017/746 (IVDR), showing where the standard partially or fully addresses regulatory requirements.
- Regulatory processes to integrate into QMS: The amendment highlights the need to incorporate processes such as clinical evaluation, risk management, post-market surveillance (PMS) and unique device identification (UDI) into the QMS in accordance with EU rules.
- Limitations and partial coverage: EN ISO 13485 remains an international standard; many EU-specific details (e.g., formats and timelines for vigilance, exact UDI system implementation, EU Declaration of Conformity specifics) are noted as not fully covered and must be implemented by manufacturers per the Regulations.
- Normative references: Cross-references to standards like ISO 9000:2015/EN ISO 9000 are maintained for terminology and QMS fundamentals.
Practical applications and users
This amendment is intended for:
- Medical device manufacturers implementing or updating a QMS to demonstrate regulatory compliance in Europe.
- Regulatory affairs and quality managers aligning internal processes with MDR/IVDR expectations.
- Notified bodies and conformity assessment bodies using the mapping to assess manufacturer conformity with QMS-related regulatory requirements.
- Consultants, auditors, and suppliers supporting device manufacturers on clinical evaluation, risk management, PMS, UDI and technical documentation.
Practical use: apply EN ISO 13485:2016/A11:2021 to structure the QMS, then integrate specific EU regulatory requirements (as highlighted in Annex ZA/ZB) to achieve conformity with MDR/IVDR.
Related standards
Keywords: EN ISO 13485:2016/A11:2021, ISO 13485 amendment A11, medical devices quality management, EU MDR 2017/745, IVDR 2017/746, post-market surveillance, clinical evaluation, risk management, UDI.
